Gaomei Genetics closes multimillion-yuan Pre-A round

2020-07-29
|
Isiah Liu

Gaomei Genetics closes multimillion-yuan Pre-A round

Gaomei Genetics, a early cancer detection biotechnology company, has recently closed its Pre-A round, raising tens of millions of yuan.


This is the first financing for Gaomei after the successful merger of Zhejiang Gomics and Known Biotech. WinX Capital continued to serve as the sole financial advisor.


Lu Guohua, CEO of Gaomei claims that the proceeds will be primarily used to accelerate the launch of the liver cancer early detection product and the registration filing of the liver cancer early screening IVD product.


In the meantime, further expand the company’s leading advantages in the multi-cancer early detection database, which already covers the top 10 common cancers in the Chinese population, and continue to promote research and development of technologies for early detection of gastrointestinal and gynecological tumors.


Located in Nanjing, Gaomei Genetics is a high-tech enterprise focusing on tumor epigenetics and large-scale data analysis, covering early cancer screening, accompanying diagnosis, dynamic monitoring, prognosis assessment, among others.



RELATED ARTICLES

Eugenlight Technologies closes Series A of RMB tens of millions
2020-09-13
|
PEVC , Semiconductor , Electroinic

BPassword closes angel round led by Eagle Fund
2020-09-13
|
PEVC , Blockchain

Microtera Semiconductor closes Series A with RMB tens of millions
2020-09-13
|
PEVC , Semiconductor

Vertex Ventures completes new fund raising of RMB three bln
2020-09-13
|
PEVC , Technology , Semiconductor

Xiaoyinghe closes seed round of two mln yuan
2020-09-12
|
PEVC , Internet

Orthopedic AI company Changmugu closes Series A+ of RMB tens of mlns
2020-09-12
|
PEVC , Medical care

Young More nets tens of millions of yuan in strategic financing from Autek & Netac
2020-06-21
|
PEVC , Medical care

Oceanus+ closes multi-million-yuan Series A+ round led by Med-Fine Capital
2020-05-15
|
PEVC , Medical care

BCTK closes Series A, raises nearly RMB60m
2020-05-07
|
PEVC , Medicine
China SDG